Taylor Wessing advised Phagenesis on its financing round. Phagenesis, a medical device company founded in 2007 by Dr. Conor Mulrooney and Professor Shaheen Hamdy, has secured...
Phagenesis’ $42m Series D Financing Round
CUBE Global’s Strategic Growth Investment From Bregal Milestone
Taylor Wessing advised CUBE Global on the deal. The investment marks the first institutional capital investment for CUBE. Serving a number of the world’s largest financial...
Gravity Sketch’s $33 Million Series A Funding Round
Taylor Wessing advised Gravity Sketch on the deal. Marriott Harrison represented Accel. 3D creation and collaboration start-up Gravity Sketch has successfully completed its $33 million Series...
SEON’s $94 Million Series B Funding Round
Taylor Wessing advised SEON on the deal. London-based Anglo-Hungarian start-up SEON has raised $94 million in its Series B funding round, forging the company’s path towards...
Halozyme Therapeutics’ Acquisition of Antares Pharma
Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...
PassFort’s Exit to Moody’s Corporation
Taylor Wessing advised PassFort on the deal. PassFort is a UK SaaS-based workflow platform for identity verification, customer onboarding, and risk analysis. Its software delivers data...
Yoto Limited’s $17 million Series A Funding
CMS advised Acton Capital on the deal. Taylor Wessing and Wilson Sonsini Goodrich & Rosati advised Yoto. Acton Capital acted as lead investor on the $17 million...